Atila Tatlışen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Atila Tatlışen has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Demirtas
Department of Urology, Erciyes University, Kayseri, Turkey
6 shared publications E.C. Akinsal
3 shared publications- Gökhan Sönmez
Department of Urology, Erciyes University Faculty of Medicine, Kayseri, Turkey
3 shared publications - Numan Baydilli
Department of Pediatric Urology, Erciyes University Faculty of Medicine, Kayseri, Turkey
3 shared publications V. Sabur
3 shared publications- Şevket Tolga Tombul
Erciyes University, Department of Urology, Kayseri, Turkey
3 shared publications
Latest Publications
- 1 January 2022
- Published by Elsevier in Actas Urológicas Españolas (English Edition)
- Vol. 46 (1) , 35-40
Superselective vesical artery embolization versus intravesical formalin for intractable hematuria in patients with bladder cancer
- 1 January 2022
- Published by Elsevier in Actas Urológicas Españolas (English Edition)
- Vol. 46 (1) , 35-40
Superselective vesical artery embolization versus intravesical formalin for intractable hematuria in patients with bladder cancer
- 1 December 2020
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 19 (4) , 182-185
Intravesical Mitomycin-C with Bladder Wall Hyperthermia in Intermediate and High-risk Non-muscle Invasive Bladder Cancers: Prospective Clinical Trial with a Singletreatment Arm
- 1 December 2020
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 19 (4) , 182-185
Intravesical Mitomycin-C with Bladder Wall Hyperthermia in Intermediate and High-risk Non-muscle Invasive Bladder Cancers: Prospective Clinical Trial with a Singletreatment Arm
- 1 January 2019
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 45 (3) , 196-201
Multiparametric MRI fusion-guided prostate biopsy in biopsy naive patients: Preliminary results from 80 patients
Objective: The aim of this prospective study was to evaluate the early results of transrectal prostate biopsies performed under the guidance of multiparametric prostate magnetic resonance imaging (mpMRI) in biopsy naive patients. Material and methods: Biopsy naive patients who had prostate-specific antigen level 4–10 ng/mL and/or abnormal digital rectal examination findings and provided informed consent were examined using mpMRI. The study included 80 patients with an MRI-defined lesion with a Prostate Imaging and Reporting and Data System (PIRADS) score of ≥3. All mpMRIs were reported by the same uro-radiologist according to PIRADS version 2. An MRI-targeted biopsy was performed by an ultrasonography system with rigid fusion registration software. The first two to five core biopsies per MRI-defined lesions were obtained, and then a standard random 12-core biopsy was performed. Transrectal biopsies were performed under local anesthesia or sedoanalgesia. Results: Of the 80 patients, 29 (36.3%) were found to have cancer using the conventional 12-core biopsy, but only 20 (25%) were found to have prostate cancer using the MRI-targeted prostate biopsy. Combining the two biopsy methods (conventional+MRI-targeted), cancer detection rate increased to 43.8% (35/80 patients). The cancer detection rate using the combined method was statistically higher than that using the conventional biopsy method (p=0.03). Using the conventional biopsy method, 960 core biopsies were collected from 80 patients. Of the 960 core biopsies, 111 (11.6%) were found to be cancer. Further, 101 suspected lesions were detected using mpMRI in 80 patients. In addition, 397 core biopsies were obtained from these lesions. Of the 397 core biopsies, 62 (15.6%) were reported as prostate cancer. The core positivity rate of MR-targeted biopsy was statistically higher than that of conventional biopsy (p=0.04). Conclusion: The preliminary results of MRI-targeted prostate biopsy combined with conventional biopsy suggested that the combined biopsy method was crucial in prostate cancer diagnosis especially in patients with prostate cancer suspicion and no biopsy history. However, larger sample prospective studies are needed to validate the effectiveness of MRI-targeted biopsy and combined biopsy methods. Cite this article as: Sönmez G, Tombul ŞT, İmamoğlu H, Akgün H, Demirtaş A, Tatlışen A. Multiparametric MRI fusion-guided prostate biopsy in biopsy naive patients: Preliminary results from 80 patients. Turk J Urol 2019; 45(3): 196-201.
- 1 January 2019
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 45 (3) , 196-201
Multiparametric MRI fusion-guided prostate biopsy in biopsy naive patients: Preliminary results from 80 patients
Objective: The aim of this prospective study was to evaluate the early results of transrectal prostate biopsies performed under the guidance of multiparametric prostate magnetic resonance imaging (mpMRI) in biopsy naive patients. Material and methods: Biopsy naive patients who had prostate-specific antigen level 4–10 ng/mL and/or abnormal digital rectal examination findings and provided informed consent were examined using mpMRI. The study included 80 patients with an MRI-defined lesion with a Prostate Imaging and Reporting and Data System (PIRADS) score of ≥3. All mpMRIs were reported by the same uro-radiologist according to PIRADS version 2. An MRI-targeted biopsy was performed by an ultrasonography system with rigid fusion registration software. The first two to five core biopsies per MRI-defined lesions were obtained, and then a standard random 12-core biopsy was performed. Transrectal biopsies were performed under local anesthesia or sedoanalgesia. Results: Of the 80 patients, 29 (36.3%) were found to have cancer using the conventional 12-core biopsy, but only 20 (25%) were found to have prostate cancer using the MRI-targeted prostate biopsy. Combining the two biopsy methods (conventional+MRI-targeted), cancer detection rate increased to 43.8% (35/80 patients). The cancer detection rate using the combined method was statistically higher than that using the conventional biopsy method (p=0.03). Using the conventional biopsy method, 960 core biopsies were collected from 80 patients. Of the 960 core biopsies, 111 (11.6%) were found to be cancer. Further, 101 suspected lesions were detected using mpMRI in 80 patients. In addition, 397 core biopsies were obtained from these lesions. Of the 397 core biopsies, 62 (15.6%) were reported as prostate cancer. The core positivity rate of MR-targeted biopsy was statistically higher than that of conventional biopsy (p=0.04). Conclusion: The preliminary results of MRI-targeted prostate biopsy combined with conventional biopsy suggested that the combined biopsy method was crucial in prostate cancer diagnosis especially in patients with prostate cancer suspicion and no biopsy history. However, larger sample prospective studies are needed to validate the effectiveness of MRI-targeted biopsy and combined biopsy methods. Cite this article as: Sönmez G, Tombul ŞT, İmamoğlu H, Akgün H, Demirtaş A, Tatlışen A. Multiparametric MRI fusion-guided prostate biopsy in biopsy naive patients: Preliminary results from 80 patients. Turk J Urol 2019; 45(3): 196-201.
- 1 October 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (4)
S251 The results of radical nephrectomy
- 1 October 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (4)
S251 The results of radical nephrectomy
- 1 October 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (4)
S107 Our experience in upper urinary tract urothelial tumors
- 1 October 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (4)
S107 Our experience in upper urinary tract urothelial tumors
- 1 June 1995
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 153 (6) , 1895-1896
Sarcomatoid Squamous Cell Carcinoma of the Right Renal Pelvis with Liver Metastasis: Case Report
We report on a man with sarcomatoid squamous cell carcinoma of the right kidney with liver metastases. Bilateral renal lithiasis and well differentiated squamous cell carcinomas of the right renal pelvis were also noted. This uncommon case is discussed and the literature is reviewed.
- 1 June 1995
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 153 (6) , 1895-1896
Sarcomatoid Squamous Cell Carcinoma of the Right Renal Pelvis with Liver Metastasis: Case Report
We report on a man with sarcomatoid squamous cell carcinoma of the right kidney with liver metastases. Bilateral renal lithiasis and well differentiated squamous cell carcinomas of the right renal pelvis were also noted. This uncommon case is discussed and the literature is reviewed.